(Q45290030)

11 December 2017

title

Dopamine D1 receptor number--a sensitive PET marker for early brain degeneration in Huntington's disease (English)

1 reference

11 December 2017

0 references

0 references

6

C Halldin

1 reference

11 December 2017

G Sedvall

1

1 reference

11 December 2017

P Karlsson

2

1 reference

11 December 2017

A Lundin

3

1 reference

11 December 2017

M Anvret

4

1 reference

11 December 2017

T Suhara

5

1 reference

11 December 2017

L Farde

7

1 reference

11 December 2017

publication date

1 January 1994

1 reference

European Archives of Psychiatry and Clinical Neuroscience

11 December 2017

published in

1 reference

11 December 2017

volume

243

1 reference

11 December 2017

issue

5

1 reference

11 December 2017

page(s)

249-255

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02191583

11 December 2017

exact match

0 references

cites work

D2 receptors in Huntington's disease: positron emission tomography findings and clinical correlates

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02191583

The combined use of positron emission tomography and DNA polymorphisms for preclinical detection of Huntington's disease

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02191583

Alterations in dopaminergic receptors in Huntington's disease

21 January 2018

1 reference

12 December 2020

Reduced regional cerebral blood flow in Huntington's disease studied by SPECT.

1 reference

12 December 2020

Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington's disease

1 reference

12 December 2020

A dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions

1 reference

12 December 2020

An immunohistochemical investigation of the human neostriatum in Huntington's disease

1 reference

12 December 2020

Neuropeptide Y, somatostatin, and reduced nicotinamide adenine dinucleotide phosphate diaphorase in the human striatum: a combined immunocytochemical and enzyme histochemical study.

1 reference

12 December 2020

The measurement of abnormal movement: methods developed for Huntington's disease

1 reference

12 December 2020

Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease

1 reference

12 December 2020

Nigral dopamine type-1 receptors are reduced in Huntington's disease: a postmortem autoradiographic study using [3H]SCH 23390 and correlation with [3H]forskolin binding

1 reference

12 December 2020

Huntington's disease. Pathogenesis and management

1 reference

12 December 2020

Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases

1 reference

12 December 2020

Heterogeneous dopamine receptor changes in early and late Huntington's disease

1 reference

12 December 2020

Stereoselective binding of 11C-raclopride in living human brain--a search for extrastriatal central D2-dopamine receptors by PET.

1 reference

12 December 2020

Positron emission tomographic scan investigations of Huntington's disease: cerebral metabolic correlates of cognitive function

1 reference

12 December 2020

The neostriatal mosaic: compartmental distribution of calcium-binding protein and parvalbumin in the basal ganglia of the rat and monkey

1 reference

12 December 2020

Preparation of 11C-labelled SCH 23390 for the in vivo study of dopamine D-1 receptors using positron emission tomography

1 reference

12 December 2020

Comparison of the distributions of D1 and D2 dopamine receptor mRNAs in rat brain

1 reference

12 December 2020

Proliferative and degenerative changes in striatal spiny neurons in Huntington's disease: a combined study using the section-Golgi method and calbindin D28k immunocytochemistry

1 reference

12 December 2020

Dopamine D-1 and D-2 receptors in Huntington's disease.

1 reference

12 December 2020

Head fixation device for reproducible position alignment in transmission CT and positron emission tomography

1 reference

12 December 2020

Dopamine receptors in human brain: autoradiographic distribution of D1 and D2 sites in Parkinson syndrome of different etiology

1 reference

12 December 2020

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

1 reference

12 December 2020

Neuropathological classification of Huntington's disease

1 reference

12 December 2020

1 reference

12 December 2020

Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET.

1 reference

12 December 2020

Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington's disease and schizophrenia

1 reference

12 December 2020

Dopamine receptor properties in Parkinson's disease and Huntington's chorea evaluated by positron emission tomography using 11C-N-methyl-spiperone

1 reference

12 December 2020

Human dopamine receptor subtypes--in vitro binding analysis using 3H-SCH 23390 and 3H-raclopride

1 reference

12 December 2020

Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease

1 reference

12 December 2020

Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease

1 reference

12 December 2020

Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography

1 reference

12 December 2020

DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization.

1 reference

12 December 2020

1 reference

12 December 2020

PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02191583

1 reference

Dimensions Publication ID

11 December 2017

1004818561

0 references

1 reference